Delivery Order SPE2DR25D3301-SPE2DR26F21PE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of epinephrine 0.3 mg auto-injector packs (two-count units) with a ceiling value of $1,923.88. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania, and scheduled for completion by January 23, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $2,264.83 and an ultimate completion date of January 15, 2026. This non-set-aside contract was competitively awarded and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026),...
- The Defense Logistics Agency awarded a $1,023.31 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.15 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $2,954.20. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,317.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) on January 28, 2026, with completion scheduled for January 29, 2026. This is a non-set-aside competitive award executed at the Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,141.36 to AmerisourceBergen Drug Corp on January 15, 2026, for the procurement of Epinephrine 0.3 mg auto-injector two-packs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 16, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not issued under any set-aside designation, indicating the contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,401.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,716.00 and an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,278.57 and is set to conclude by December 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F21PEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,140.82 and an ultimate completion date of February 2, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contracts supplying critical medical commodities including specialty medications, generic and brand-name drugs, vaccines, and medical devices across multiple therapeutic domains. The company's parent organization, Cencora, Inc., holds the significant DLA IDC that enables flexible fulfillment of medical supply needs for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This particular delivery order for epinephrine auto-injectors represents a routine procurement of emergency medical supplies critical to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 1/29/26 |